Nuclear Magnetic Resonance Based Profiling of Biofluids Reveals Metabolic Dysregulation in HIV-Infected Persons and Those on Anti-Retroviral Therapy

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Munshi, Saif Ullah ^a   Rewari, Bharat Bhushan ^b   Bhavesh, Neel Sarovar ^a   Jameel, Shahid ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b National AIDS Control Organization   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLGLUTARIC ACID; ACETOACETIC ACID; ALANINE; ALCOHOL; ALPHA TOCOPHEROL; ANTIRETROVIRUS AGENT; ASPARTIC ACID; BUTYRIC ACID; CHOLESTANOL; CHOLINE; EFAVIRENZ; FORMIC ACID; GLUCOSE; GLUTAMIC ACID; GLUTARIC ACID DERIVATIVE; GLYCOLIC ACID; LACTIC ACID; LAMIVUDINE; LYSINE; METHIONINE; METHYLMALONIC ACID; NEOPTERIN; NEVIRAPINE; PROPIONIC ACID; SARCOSINE; STAVUDINE; TESTOSTERONE; THREONINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; BIOINFORMATICS; BLOOD ANALYSIS; BODY FLUID; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLITE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTIAL LEAST SQUARES REGRESSION; PRINCIPAL COMPONENT ANALYSIS; SALIVA ANALYSIS; STATISTICAL MODEL; URINALYSIS; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; YOUNG ADULT;

EID: 84877824090     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064298     Document Type: Article

References (62)

1. Vorster HH, Kruger A, Margetts BM, Venter CS, Kruger HS, et al. (2004) The nutritional status of asymptomatic HIV-infected Africans: directions for dietary intervention? Public Health Nutr 7: 1055-1064.
2. Gasparis AP, Tassiopoulos AK, (2001) Nutritional support in the patient with HIV infection. Nutrition 17: 981-982.
3. Grinspoon S, Mulligan K, (2003) Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis 36: S69-S78.
4. Salas-Salvadó J, Garcia-Lorda P, (2001) The metabolic puzzle during the evolution of HIV infection. Clin Nutr 20: 379-391.
5. Sharpstone DR, Murray CP, Ross HM, Hancock MR, Phelan MS, et al. (1996) Energy balance in asymptomatic HIV infection. AIDS 10: 1377-1384.
6. Grunfeld C, Pang M, Shimizu L, Shigenaga JK, Jensen P, et al. (1992) Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 55: 455-460.
7. Garcõa-Lorda P, Serrano P, Jimenez-Exposito MJ, Fraile J, Bulló M, et al. (2000) Cytokine-driven infammatory response is associated with the hypermetabolism of AIDS patients with opportunistic infections. J Parent Ent Nutr 24: 317-322.
8. Nicholson JK, Connelly J, Lindon JC, Holmes E, (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1: 153-161.
9. Brindle J, Antti H, Holmes E, Tranter G, Nicholson JK, et al. (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 8: 1439-1444.
10. Ghauri FY, Nicholson JK, Sweatman BC, Wood J, Beddell CR, et al. (1993) NMR spectroscopy of human post mortem cerebrospinal fluid: distinction of Alzheimer's disease from control using pattern recognition and statistics. NMR Biomed 6: 163-167.
11. Mao Y, Huang X, Yu K, Qu HB, Liu CX, et al. (2008) Metabonomic analysis of hepatitis B virus-induced liver failure: identification of potential diagnostic biomarkers by fuzzy support vector machine. J Zhejiang Univ Sci B 9: 474-481.
12. Godoy MM, Lopes EP, Silva RO, Hallwass F, Koury LC, et al. (2010) Hepatitis C virus infection diagnosis using metabonomics. J Viral Hepat 17: 854-858.
13. Munshi SU, Taneja S, Bhavesh NS, Shastri J, Aggarwal R, et al. (2011) Metabonomic analysis of hepatitis E patients shows deregulated metabolic cycles and abnormalities in amino acid metabolism. J Viral Hepat 18: e591-602.
14. Coen M, O'Sullivan M, Bubb WA, Kuchel PW, Sorrell T, (2005) Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis. Clin Infect Dis 41: 1582-1590.
15. Philippeos C, Steffens FE, Meyer D, (2009) Comparative 1H NMR-based metabonomic analysis of HIV-1 sera. J Biomol NMR 44: 127-137.
16. Hewer R, Vorster J, Steffens FE, Meyer D, (2006) Applying biofluid 1H NMR based metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative individuals. J Pharm Biomed Anal 41: 1442-1446.
17. Ghannoum MA, Mukherjee PK, Jurevic RJ, Retuerto M, Brown RE, et al. (2011) Metabolomics Reveals Differential Levels of Oral Metabolites in HIV-Infected Patients: Toward Novel Diagnostic Targets. OMICS doi:10.1089/omi.2011.0035.
18. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, et al. (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protocol 2: 2692-2703.
19. Meiboom S, Gill D, (1958) Modified spin-echo method for measuring nuclear relaxation time. Rev Sci Instrum 20: 688-691.
20. Kamga HLF, Assob JCN, Njunda AL, Nde Fon P, Nsagha DS, et al. (2011) The kidney function trends in human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) patients at the Nylon District Hospital, Douala, Cameroon. J AIDS HIV Res 3: 30-37.
21. Xia J, Psychogios N, Young N, Wishart DS, (2009) MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 37: W652-660.
22. Kay LE, Keifer P, Saarinen T, (1992) Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J Am Chem Soc 114: 10663-10665.
23. Wishart DS, Knox C, Guo AC, Eisner R, Young N, et al. (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37: D603-610.
24. Xia J, Bjorndahl TC, Tang P, Wishart DS, (2008) MetaboMiner- semi-automated identification of metabolites from 2D NMR spectra of complex biofluids. BMC Bioinformatics 9: 507.
25. Lindon JC, Nicholson JK, Everette JR, (1999) NMR spectroscopy of biofluids. Ann Rep NMR Spectros 38: 1-88.
26. Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC, (1996) 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem 67: 793-811.
27. Xia J, Wishart DS, (2010) MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics 26: 2342-2344.
28. Lundstedt T, Seifert E, Abramo L, Thelin B, Nyström A, et al. (1998) Experimental design and optimization. Chemom Intell Lab Syst 42: 3-40.
29. Tan J, Li QQ, Loganath A, Chong YS, Xiao M, et al. (2008) Multivariate data analyses of persistent organic pollutants in maternal adipose tissue in Singapore. Environ Sci Technol 42: 2681-2687.
30. Wanchu A, Bhatnagar A, Khullar M, Sud A, Bambery P, et al. (2002) Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients. BMC Infect Dis 2: 15.
31. Hortin GL, Landt M, Powderly WG, (1994) Changes in plasma amino acid concentrations in response to HIV-1 infection. Clin Chem 40: 785-789.
32. Laurichesse H, Tauveron I, Gourdon F, Cormerais L, Champredon C, et al. (1998) Threonine and methionine are limiting amino acids for protein synthesis in patients with AIDS. J Nutr 128: 1342-1348.
33. Di Rocco A, Bottiglieri T, Werner P, Geraci A, Simpson D, et al. (2002) Abnormal cobalamin-dependent transmethylation in AIDS-associated myelopathy. Neurology 58: 730-735.
34. Steiber A, Kerner J, Hoppel C, (2004) Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 25: 455-473.
35. De Simone C, Tzantzoglou S, Jirillo E, Marzo A, Vullo V, et al. (1992) L-Carnitine deficiency in AIDS patients. AIDS 6: 203-205.
36. Alani A, Vincent O, Adewumi A, Titilope A, Onogu E, et al. (2010) Plasma folate studies in HIV-positive patients at the Lagos university teaching hospital, Nigeria. Indian J Sex Transm Dis 31: 99-103.
37. Grunfeld C, Feingold KR, (1992) Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 327: 329-37.
38. Murr C, Widner B, Wirleitner B, Fuchs D, (2002) Neopterin as a marker for immune system activation. Curr Drug Metab 3: 175-187.
39. Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, et al. (1990) The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 322: 166-172.
40. Jordão Júnior AA, Silveira S, Figueiredo JF, Vannucchi H, (1998) Urinary excretion and plasma vitamin E levels in patients with AIDS. Nutrition14: 423-426.
41. Ironson G, Balbin E, Stieren E, Detz K, Fletcher MA, et al. (2008) Perceived stress and norepinephrine predict the effectiveness of response to protease inhibitors in HIV. Int J Behav Med 15: 221-226.
42. Hughes JW, Watkins L, Blumenthal JA, Kuhn C, Sherwood A, (2004) Depression and anxiety symptoms are related to increased 24- hour urinary norepinephrine excretion among healthy middle-aged women. J Psychosom Res 57: 353-358.
43. Sundstrom JB, Martinson DE, Mosunjac M, Bostik P, McMullan LK, et al. (2003) Norepinephrine enhances adhesion of HIV-1-infected leukocytes to cardiac microvascular endothelial cells. Exp Biol Med 228: 730-740.
44. Meyerhoff DJ, Bloomer C, Cardenas V, Norman D, Weiner MW, et al. (1999) Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV patients. Neurology 52: 995-1003.
45. Roser W, Hagberg G, Mader I, Brunnschweiler H, Radue EW, et al. (1995) Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med 33: 811-817.
46. de Gans J, Portegies P, (1989) Neurological complications of infection with human immunodeficiency virus type 1. A review of literature and 241 cases. Clin Neurol Neurosurg 91: 199-219.
47. Dobs AS, Few WL III, Blackman MR, Harman SM, Hoover DR, et al. (1996) Serum hormones in men with human immunodeficiency virus-associated wasting. J Clin Endocrinol 81: 4108-4112.
48. Rietschel P, Corcoran C, Stanley T, Basgoz N, Klibanski A, et al. (2000) Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin Infect Dis 31: 1240-1244.
49. Flyckt RL, Liu J, Frasure H, Wekselman K, Buch A, et al. (2009) Comparison of salivary versus serum testosterone levels in postmenopausal women receiving transdermal testosterone supplementation versus placebo. Menopause 16: 680-688.
50. Teichmann J, Stephan E, Lange U, Discher T, Federlin K, et al. (1998) Evaluation of serum and urinary estrogen levels in male patients with HIV-infection. Eur J Med Res 3: 533-537.
51. Teichmann J, Schmidt A, Lange U, Stracke H, Discher T, et al. (2003) Longitudinal evaluation of serum estradiol and estrone in male patients infected with the human immunodeficiency virus. Eur J Med Res 8: 77-80.
52. Mataftsi M, Skoura L, Sakellari D, (2011) HIV infection and periodontal diseases: an overview of the post-HAART era. Oral Dis 17: 13-25.
53. Imai K, Ochiai K, Okamoto T, (2009) Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. J Immunol 182: 3688-3695.
54. Carr A, (2003) Lactic acidemia in infection with human immunodeficiency virus. Clin Infect Dis 36: S96-S100.
55. Madigan A, Murray PA, Houpt M, Catalanotto F, Feuerman M, (1996) Caries experience and cariogenic markers in HIV-positive children and their siblings. Pediatr Dent 18: 129-136.
56. Barchiesi F, Maracci M, Radi B, Arzeni D, Baldassarri I, et al. (2002) Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy. J Antimicrob Chemother 50: 999-1002.
57. Chen H, Zha J, Gowans RE, Camargo P, Nishitani J, et al. (2004) Alcohol enhances HIV type 1 infection in normal human oral keratinocytes by up-regulating cell-surface CXCR4 coreceptor. AIDS Res Hum Retroviruses 20: 513-519.
58. Meyer SA, (1996) B12: Dementia and Cognition. A review of HIV-related Vitamin B12 deficiency, cognition and dementia. HIV ReSource Review 1: 1-12.
59. Weis BC, Margolis D, Burgess SC, Merritt ME, Wise H, et al. (2004) Glucose production pathways by 2H and 13C NMR in patients with HIV-associated lipoatrophy. Magn Reson Med 51: 649-654.
60. Hortin GL, Landt M, Powderly WG, (1994) Changes in plasma amino acid concentrations in response to HIV-1 infection. Clin Chem 40: 785-789.
61. Yarasheski KE, Smith SR, Powderly WG, (2005) Reducing plasma HIV RNA improves muscle amino acid metabolism. Am J Physiol Endocrinol Metab 288: E278-284.
62. Li P, Yin YL, Li D, Kim SW, Wu G, (2007) Amino acids and immune function. Br J Nutr 98: 237-252.